0001562180-19-000371.txt : 20190118 0001562180-19-000371.hdr.sgml : 20190118 20190118173731 ACCESSION NUMBER: 0001562180-19-000371 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190116 FILED AS OF DATE: 20190118 DATE AS OF CHANGE: 20190118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARSCADDEN GWEN R. CENTRAL INDEX KEY: 0001590948 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 19533920 MAIL ADDRESS: STREET 1: C/O INTERSECT ENT, INC. STREET 2: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-01-16 false 0001271214 Intersect ENT, Inc. XENT 0001590948 CARSCADDEN GWEN R. C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false Chief People Officer Common Stock 2019-01-16 4 A false 4500.00 0.00 A 12179.00 D Stock Option (right to buy) 28.58 2019-01-16 4 A false 21000.00 0.00 A 2029-01-15 Common Stock 21000.00 21000.00 D Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing on January 1, 2019. Includes 9,533 Restricted Stock Units. The vesting commencement date of the option is January 1, 2019. 1/8th of the shares subject to the option shall vest on July 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. David A. Lehman, Attorney-in-Fact for Gwen Carscadden 2019-01-18